{"database": "lobbying", "table": "lobbying_activities", "rows": [[1333102, "085941b9-a3d3-46da-b778-e1bb0df09022", "Q4", "VAN HEUVELEN STRATEGIES, LLC", 321874, "GENERIC PHARMACEUTICAL ASSOCIATION", 2012, "fourth_quarter", "CSP", "Prescription drug user fee act and other issues related to generic drugs; Generic Drug User Fee Act, S.3187 Food and Drug Administration Safety and Innovation Act, S.2295 the Patient Safety and Generic Labeling Improvement Act, issues related to patent settlements; H.R.6433, FDA User Fee Corrections Act of 2012.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2013-01-11T15:36:28.543000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1333102"], "units": {}, "query_ms": 0.2888268791139126, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}